These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 15158065)
1. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems. Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065 [TBL] [Abstract][Full Text] [Related]
2. Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors. Tobler LH; Stramer SL; Lee SR; Baggett D; Wright D; Hirschkorn D; Walsh I; Busch MP Vox Sang; 2005 Nov; 89(4):201-7. PubMed ID: 16262752 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay. Tillmann HL; Wiegand J; Glomb I; Jelineck A; Picchio G; Wedemeyer H; Manns MP Z Gastroenterol; 2005 Jan; 43(1):11-6. PubMed ID: 15650966 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Bouvier-Alias M; Patel K; Dahari H; Beaucourt S; Larderie P; Blatt L; Hezode C; Picchio G; Dhumeaux D; Neumann AU; McHutchison JG; Pawlotsky JM Hepatology; 2002 Jul; 36(1):211-8. PubMed ID: 12085367 [TBL] [Abstract][Full Text] [Related]
6. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo. Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867 [TBL] [Abstract][Full Text] [Related]
7. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response. Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997 [TBL] [Abstract][Full Text] [Related]
8. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C. Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta. Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156 [TBL] [Abstract][Full Text] [Related]
10. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication. Dansako H; Ikeda M; Abe K; Mori K; Takemoto K; Ariumi Y; Kato N Virus Res; 2008 Oct; 137(1):72-9. PubMed ID: 18602954 [TBL] [Abstract][Full Text] [Related]
11. The role of core antigen detection in management of hepatitis C: a critical review. Seme K; Poljak M; Babic DZ; Mocilnik T; Vince A J Clin Virol; 2005 Feb; 32(2):92-101. PubMed ID: 15653411 [TBL] [Abstract][Full Text] [Related]
12. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8. Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587 [TBL] [Abstract][Full Text] [Related]
13. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication. Ando M; Korenaga M; Hino K; Ikeda M; Kato N; Nishina S; Hidaka I; Sakaida I Liver Int; 2008 Sep; 28(8):1158-66. PubMed ID: 18410284 [TBL] [Abstract][Full Text] [Related]
15. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells. Lin K; Kwong AD; Lin C Antimicrob Agents Chemother; 2004 Dec; 48(12):4784-92. PubMed ID: 15561857 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Kim M; Shin D; Kim SI; Park M Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254 [TBL] [Abstract][Full Text] [Related]
17. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy. Zanetti AR; Romanò L; Brunetto M; Colombo M; Bellati G; Tackney C J Med Virol; 2003 May; 70(1):27-30. PubMed ID: 12629640 [TBL] [Abstract][Full Text] [Related]
18. [Basic examination of hepatitis C virus (HCV) core protein quantitative method and the clinical significance in during the follow-up of the patients after interferon treatment]. Suyama Y; Mishima S; Iwata Y; Ishikura H; Shibata H; Masuda J Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 1999; 10(1):13-9. PubMed ID: 10415445 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976 [TBL] [Abstract][Full Text] [Related]
20. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]